Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study attempts to compare safety and long-term oncological outcomes between laparoscopic surgery and open surgery in the treatment of clinical T4b Colorectal cancer.
Laparoscopic surgery is controversial for patients with T4b colorectal cancer who require multivisceral resection. With the expansion of the indications for laparoscopic surgery in recent years, surgeons try to perform laparoscopic multivisceral resection for the treatment of clinical T4b colorectal cancer. In this study, investigators attempted to compare safety and long-term oncological outcomes between laparoscopic surgery and open surgery in the treatment of clinical T4b colorectal cancer.
This study was a multicenter retrospective cohort study based on a multicenter database which contained hospitalization. According to the operation method, the patients were divided into laparoscopic multivisceral resection group(patients who underwent laparoscopic surgery or conversion to open surgery) and open multivisceral resection group(patients who underwent open surgery directly). The short-term and long-term result was compared between groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Laparoscopic multivisceral resection group | Patients who underwent laparoscopic multivisceral resection for clinical T4b colorectal cancer |
| |
| Open multivisceral resection group | Patients who underwent open multivisceral resection for clinical T4b colorectal cancer |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Laparoscopic surgery | Procedure | The laparoscopic approach was used for the treatment of clinical T4b colorectal cancer |
|
| Measure | Description | Time Frame |
|---|---|---|
| Blood loss | Blood loss is defined as intraoperative blood loss and measured in milliliters(ml). | Until the end of the operation, an average of 8 hours. |
| Complications | Complications are defined as all surgery-related adverse events postoperatively, such as anastomotic leak, infection, which are measured in frequency. | Until the patient recovered and was discharged from the hospital, an average of 10 days. |
| Hospital stay after surgery | Hospital stay after surgery is defined as the length of time from the end of surgery to the discharge of patient, which is measured in days. | Until the patient recovered and was discharged from the hospital, an average of 10 days. |
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival | Overall survival is defined as the time from the surgery to death or last follow-up, regardless of disease recurrence, which was measured in months. | The endpoint of the overall survival assessment is the last follow-up or patient death. Follow-up time is up to 72 months. |
| Disease-free survival |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patients with distant metastasis or recurrent colorectal cancer were excluded.
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | Beijing Municipality | 100021 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38086316 | Derived | Zhang J, Sun J, Liu J, Mei S, Quan J, Hu G, Li B, Zhuang M, Wang X, Tang J. Comparison of short- and long-term outcomes between laparoscopic and open multivisceral resection for clinical T4b colorectal cancer: A multicentre retrospective cohort study in China. Eur J Surg Oncol. 2024 Jan;50(1):107316. doi: 10.1016/j.ejso.2023.107316. Epub 2023 Dec 7. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Disease-free survival is defined as the time from the surgery to disease recurrence or last follow-up, which was measured in months. |
| The endpoint of the disease-free survival assessment is the last follow-up or disease recurrence. Follow-up time is up to 72 months. |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010535 | Laparoscopy |
| ID | Term |
|---|---|
| D004724 | Endoscopy |
| D003949 | Diagnostic Techniques, Surgical |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D019060 | Minimally Invasive Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided